Down -17.59% in 4 Weeks, Here's Why You Should You Buy the Dip in Aveanna (AVAH)
Aveanna (AVAH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Aveanna Healthcare Holdings Inc. (AVAH) Q3 2024 Earnings Call Transcript
Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Debbie Stewart - Chief Accounting Officer Jeff Shaner - Chief Executive Officer Matt Buckhalter - Chief Financial Officer Conference Call Participants Ben Hendrix - RBC Capital Markets Pito Chickering - Deutsche Bank Brian Tanquilut - Jefferies Grayson McAlister - Truist Securities Operator Good morning, and welcome to the Aveanna Healthcare Holdings Third Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A.
Aveanna (AVAH) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Aveanna Healthcare (AVAH) Surpasses Q3 Earnings and Revenue Estimates
Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.03 per share a year ago.
New Strong Buy Stocks for October 25th
KGC, ORLA, CVNA, CAVA and AVAH have been added to the Zacks Rank #1 (Strong Buy) List on October 25, 2024.
Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year?
Here is how Aveanna Healthcare (AVAH) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Aveanna Healthcare (AVAH) Is Up 2.41% in One Week: What You Should Know
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Fast-paced Momentum Stock Aveanna (AVAH) Is Still Trading at a Bargain
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Is Aveanna Healthcare (AVAH) Outperforming Other Medical Stocks This Year?
Here is how Aveanna Healthcare (AVAH) and AxoGen (AXGN) have performed compared to their sector so far this year.
Why Fast-paced Mover Aveanna (AVAH) Is a Great Choice for Value Investors
Aveanna (AVAH) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Should Value Investors Buy Aveanna Healthcare (AVAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Aveanna Stock Rallies 110% in 3 Months: Is It Still Worth Buying?
AVAH stock has the potential to continue its uptrend on the back of a better payer rate environment and its focus on high-paying customers.
